AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS: Form 990, tax year 2016
View the entire original 990 at ProPublica ↗
- Organization
- AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS (EIN 23-1682043)
- Tax period
- 2016-01-01 to 2016-12-31
- Filed
- 2017-11-08
- IRS object ID
- 201723129349302332
- Schema version
- 2016v3.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2017-11-08T14:01:32-06:00 | ReturnTs |
| Tax Period End | 2016-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 521855942 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Tate and Tryon | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2021 L Street NW Suite 400 | AddressLine1Txt |
| City | Washington | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20036 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2016-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 231682043 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | American Society For Clinical | BusinessNameLine1Txt |
| Business Name Line2 | Pharmacology and Therapeutics | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | AMER | BusinessNameControlTxt |
| Phone | 7038366981 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 528 NORTH WASHINGTON STREET | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | sharon swan | PersonNm |
| Person Title | Chief Executive Officer | PersonTitleTxt |
| Phone | 7038366981 | PhoneNum |
| Signature | 2017-11-08 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | R Michael Sorrells | PreparerPersonNm |
| PTIN | P00001737 | PTIN |
| Phone | 2022932200 | PhoneNum |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 216.59.105.130 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IP | 2017-11-08 | IPDt |
| IP Tm | 14:01:28 | IPTm |
| IP Timezone | ES | IPTimezoneCd |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | 5BC65B47B3A1F1CE2534BD8A8DAEFAC1BF945F16 | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2016 | TaxYr |
| Build TS | 2021-01-29 14:40:06Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | Sharon Swan | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 528 NORTH WASHINGTON STREET | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $4,035,187 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.ASCPT.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1900 | FormationYr |
| Legal Domicile State | DC | LegalDomicileStateCd |
| Activity Or Mission | ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY. | ActivityOrMissionDesc |
| Voting Members Governing Body | 11 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 11 | VotingMembersIndependentCnt |
| Total Employee | 11 | TotalEmployeeCnt |
| Total Volunteers | 400 | TotalVolunteersCnt |
| Total Gross UBI | $2,912 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $30,259 | PYContributionsGrantsAmt |
| CY Contributions Grants | $99,311 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $1,844,898 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $3,348,943 | CYProgramServiceRevenueAmt |
| PY Investment Income | $92,934 | PYInvestmentIncomeAmt |
| CY Investment Income | $126,592 | CYInvestmentIncomeAmt |
| PY Other Revenue | $967,504 | PYOtherRevenueAmt |
| CY Other Revenue | $25,022 | CYOtherRevenueAmt |
| PY Total Revenue | $2,935,595 | PYTotalRevenueAmt |
| CY Total Revenue | $3,599,868 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $22,500 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $27,750 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $1,093,031 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $1,321,546 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $3,627 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $2,137,606 | PYOtherExpensesAmt |
| CY Other Expenses | $2,391,148 | CYOtherExpensesAmt |
| PY Total Expenses | $3,253,137 | PYTotalExpensesAmt |
| CY Total Expenses | $3,740,444 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$317,542 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$140,576 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $5,370,032 | TotalAssetsBOYAmt |
| Total Assets EOY | $5,268,980 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $172,125 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $130,112 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $5,197,907 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $5,138,868 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | Advancing clinical pharmacology, translational medicine and therapeutics for the benefit of patients and society. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $1,742,958 | ExpenseAmt |
| Grant | $27,750 | GrantAmt |
| Revenue | $1,710,104 | RevenueAmt |
| Desc | Annual Meeting: THE ASCPT ANNUAL MEETING IS AN INTERNATIONAL MEETING THAT ATTRACTS PARTICIPANTS FROM AROUND THE WORLD. A SPECTRUM OF TOPICS RELATING TO THE CONTINUUM OF DRUG DISCOVERY, DEVELOPMENT, REGULATION, AND UTILIZATION ARE DISCUSSED. THE MEETING OFFERS EDUCATIONAL SESSIONS AND POSTER PRESENTATIONS, LECTURES FROM TOP PROFESSIONALS IN THE INDUSTRY, AS WELL AS NETWORKING OPPORTUNITIES WITH CLINICAL PHARMACOLOGISTS FROM AROUND THE WORLD. THERE IS ALSO AN EXHIBIT HALL WITH REPRESENTATIVES FROM VARIOUS COMPANIES. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,149,610 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $995,220 | RevenueAmt |
| Desc | Journal: CLINICAL PHARMACOLOGY AND THERAPEUTICS (CPT) IS THE AUTHORITATIVE CROSS-DISCIPLINARY JOURNAL IN EXPERIMENTAL AND CLINICAL MEDICINE DEVOTED TO PUBLISHING ADVANCES IN THE NATURE, ACTION, EFFICACY AND EVALUATION OF THERAPEUTICS. IT CONTINUES TO SEE IMPROVEMENTS IN THE NUMBER OF MANUSCRIPTS RECEIVED AND INCREASES IN SUBSCRIPTIONS.CPT: PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY (CPT:PSP) IS AN ONLINE, FULLY OPEN ACCESS JOURNAL. CPT:PSP PROVIDES A UNIQUE INTERNATIONAL FORUM FOR SCIENTISTS IN THE PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY SPACE.Clinical and Translational Science (CTS), the newest journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. New content is published regularly. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $576,172 | ExpenseAmt |
| Revenue | $643,619 | RevenueAmt |
| Desc | Member Services: MEMBERSHIP IN ASCPT OFFERS A NUMBER OF BENEFITS WHICH DIRECTLY IMPACT ITS MEMBERS AND THEIR PROFESSIONAL DEVELOPMENT. IT PROVIDES A VARIETY OF INFORMATION TOOLS, SUCH AS THE CPT JOURNAL, WEBSITE AND EMAIL NEWSLETTER, EDUCATIONAL OPPORTUNITIES, SUCH AS THE ANNUAL MEETING, AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $3,468,740 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (1) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | 0 | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | 0 | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 46 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 11 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 11 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 11 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (1) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | The Society | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 7038366981 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 528 NORTH WASHINGTON STREET | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt |
|---|---|---|---|---|---|---|
| Kellie Reynolds PharmD | ||||||
| President | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 |
| Dan Hartman MD FCCP | ||||||
| President-Elect | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 |
| Julie A Johnson PharmD | ||||||
| Immediate Past President | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 |
| Walter Kraft MD FACP | ||||||
| Treasurer | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 |
| Anne C Heatherington PhD | ||||||
| Director | 5.00 | Yes (X) | $0 | $0 | $0 | |
| Sean Hennessy PharmD PhD | ||||||
| Director | 5.00 | Yes (X) | $0 | $0 | $0 | |
| David Y Mitchell PhD | ||||||
| Director | 5.00 | Yes (X) | $0 | $0 | $0 | |
| Virginia Ginny D Schmith PhD FCP | ||||||
| Director | 5.00 | Yes (X) | $0 | $0 | $0 | |
| Jill Fiedler-Kelly Phd | ||||||
| Director | 5.00 | Yes (X) | $0 | $0 | $0 | |
| Aubrey Stoch MD | ||||||
| Director | 5.00 | Yes (X) | $0 | $0 | $0 | |
| Paolo Vicini PhD MBA | ||||||
| Director | 5.00 | Yes (X) | $0 | $0 | $0 | |
| Sharon J Swan FASAE CAE | ||||||
| Chief Executive Officer | 60.00 | Yes (X) | $384,411 | $0 | $43,363 | |
| Elise Laffman-Johnson | ||||||
| Chief Operating Officer | 40.00 | Yes (X) | $174,038 | $0 | $12,303 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $558,449 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $55,666 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 2 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp
Contractor Name ContractorName
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | FREEMAN AUDIO VISUAL INC | BusinessNameLine1Txt |
Contractor Address ContractorAddress
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO BOX 650519 | AddressLine1Txt |
| City | DALLAS | CityNm |
| State Abbreviation | TX | StateAbbreviationCd |
| ZIP | 752650519 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Services | AUDIO VISUAL SERVICES | ServicesDesc |
| Compensation | $275,902 | CompensationAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 1 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $99,311 | AllOtherContributionsAmt |
| Total Contributions | $99,311 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| Annual Meeting Registr | 900099 | $1,281,799 | $1,281,799 | |
| journals | 900099 | $995,220 | $992,308 | $2,912 |
| Membership Dues | 900099 | $643,619 | $643,619 | |
| Exhibits | 900099 | $262,208 | $262,208 | |
| AM Sponsorships | 900099 | $166,097 | $166,097 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $3,348,943 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $74,049 | TotalRevenueColumnAmt |
| Exclusion | $74,049 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $18,060 | TotalRevenueColumnAmt |
| Exclusion | $18,060 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $487,862 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $435,319 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $52,543 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $52,543 | TotalRevenueColumnAmt |
| Exclusion | $52,543 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | Miscellaneous | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $6,962 | TotalRevenueColumnAmt |
| Exclusion | $6,962 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $6,962 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,599,868 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $3,346,031 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $2,912 | UnrelatedBusinessRevenueAmt |
| Exclusion | $151,614 | ExclusionAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $27,750 | TotalAmt |
| Program Services | $27,750 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $618,118 | TotalAmt |
| Program Services | $470,516 | ProgramServicesAmt |
| Management And General | $147,602 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $567,386 | TotalAmt |
| Program Services | $477,094 | ProgramServicesAmt |
| Management And General | $90,292 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $730 | TotalAmt |
| Management And General | $730 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $67,598 | TotalAmt |
| Program Services | $5,120 | ProgramServicesAmt |
| Management And General | $62,478 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $67,714 | TotalAmt |
| Program Services | $57,215 | ProgramServicesAmt |
| Management And General | $10,499 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,784 | TotalAmt |
| Management And General | $24,784 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $87,562 | TotalAmt |
| Program Services | $5,667 | ProgramServicesAmt |
| Management And General | $81,895 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $19,770 | TotalAmt |
| Management And General | $19,770 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $204,473 | TotalAmt |
| Program Services | $184,253 | ProgramServicesAmt |
| Management And General | $20,220 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $104,764 | TotalAmt |
| Program Services | $82,118 | ProgramServicesAmt |
| Management And General | $22,646 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $20,222 | TotalAmt |
| Management And General | $20,222 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $38,012 | TotalAmt |
| Management And General | $38,012 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $84,399 | TotalAmt |
| Program Services | $63,548 | ProgramServicesAmt |
| Management And General | $20,851 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,130,991 | TotalAmt |
| Program Services | $1,097,333 | ProgramServicesAmt |
| Management And General | $33,658 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,641 | TotalAmt |
| Management And General | $3,641 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $51,132 | TotalAmt |
| Management And General | $51,132 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $26,892 | TotalAmt |
| Management And General | $26,892 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| AWARDS/HONORARIUM | $245,961 | $234,178 | $11,783 | |
| MEMBERSHIP Services + R | $141,013 | $140,960 | $53 | |
| Strategic Plan & Busine | $116,232 | $9,513 | $103,092 | $3,627 |
| EDITORIAL EXPENSES | $50,316 | $50,316 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $40,984 | TotalAmt |
| Program Services | $563,159 | ProgramServicesAmt |
| Management And General | -$522,175 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,740,444 | TotalAmt |
| Program Services | $3,468,740 | ProgramServicesAmt |
| Management And General | $268,077 | ManagementAndGeneralAmt |
| Fundraising | $3,627 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $149,221 | BOYAmt |
| EOY | $254,442 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,243,078 | BOYAmt |
| EOY | $888,566 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,252 | BOYAmt |
| EOY | $0 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $1,108,269 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $396,115 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $740,659 | BOYAmt |
| EOY | $712,154 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,682,302 | BOYAmt |
| EOY | $2,885,173 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $550,520 | BOYAmt |
| EOY | $528,645 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,370,032 | BOYAmt |
| EOY | $5,268,980 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $66 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $131,534 | BOYAmt |
| EOY | $59,396 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $40,591 | BOYAmt |
| EOY | $70,650 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $172,125 | BOYAmt |
| EOY | $130,112 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,933,383 | BOYAmt |
| EOY | $4,854,931 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $264,524 | BOYAmt |
| EOY | $283,937 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,197,907 | BOYAmt |
| EOY | $5,138,868 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,370,032 | BOYAmt |
| EOY | $5,268,980 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$140,576 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $81,537 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Other | Yes (X) | MethodOfAccountingOtherInd |
| Accountant Compile Or Review | Yes (1) | AccountantCompileOrReviewInd |
Acct Compile Or Review Basis AcctCompileOrReviewBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| FS Audited | 0 | FSAuditedInd |
| Audit Committee | 0 | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org509a2 | Yes (X) | PubliclySupportedOrg509a2Ind |
Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $113,713 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $98,684 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $46,169 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $30,259 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $99,311 | CurrentTaxYearAmt |
| Total | $388,136 | TotalAmt |
Gross Receipts Admissions GrossReceiptsAdmissionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,006,395 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $2,615,205 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,165,820 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,790,322 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,346,031 | CurrentTaxYearAmt |
| Total | $14,923,773 | TotalAmt |
Total509 Total509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,120,108 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $2,713,889 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,211,989 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,820,581 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,445,342 | CurrentTaxYearAmt |
| Total | $15,311,909 | TotalAmt |
Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Substantial Contributors Amt SubstantialContributorsAmtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $976,902 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $932,521 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,226,890 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $916,103 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $956,864 | CurrentTaxYearAmt |
| Total | $5,009,280 | TotalAmt |
Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $976,902 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $932,521 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,226,890 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $916,103 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $956,864 | CurrentTaxYearAmt |
| Total | $5,009,280 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total509 | $10,302,629 | PublicSupportTotal509Amt |
Gross Investment Income509 GrossInvestmentIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $65,687 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $91,966 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $102,071 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $108,018 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $92,109 | CurrentTaxYearAmt |
| Total | $459,851 | TotalAmt |
Investment Income And UBTI InvestmentIncomeAndUBTIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $65,687 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $91,966 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $102,071 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $108,018 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $92,109 | CurrentTaxYearAmt |
| Total | $459,851 | TotalAmt |
Net Income From Other UBI NetIncomeFromOtherUBIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $11,287 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $7,707 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,134 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $0 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $0 | CurrentTaxYearAmt |
| Total | $22,128 | TotalAmt |
Other Income509 OtherIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $18,301 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,885 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $12,186 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $3,547 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $6,962 | CurrentTaxYearAmt |
| Total | $42,881 | TotalAmt |
Total Support Calendar Year TotalSupportCalendarYearGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,215,383 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $2,815,447 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,329,380 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,932,146 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,544,413 | CurrentTaxYearAmt |
| Total | $15,836,769 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support CY509 | 0.65060 | PublicSupportCY509Pct |
| Investment Income CY | 0.02900 | InvestmentIncomeCYPct |
| Thirty Thr Pct Suprt Tests CY509 | Yes (X) | ThirtyThrPctSuprtTestsCY509Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule A, Part III, Line 12, Explanation of Other Income: | FormAndLineReferenceDesc |
| Explanation | Income from Activities not Normally Recurring | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $3,720,673 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $3,720,673 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $336,034 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $84,009 | FilingOrganizationsTotalAmt |
Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $281,814 | CurrentYearMinus3Amt |
| Current Year Minus2 | $287,046 | CurrentYearMinus2Amt |
| Current Year Minus1 | $311,662 | CurrentYearMinus1Amt |
| Current Year | $336,034 | CurrentYearAmt |
| Total | $1,216,556 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $1,824,834 | LobbyingCeilingAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $70,454 | CurrentYearMinus3Amt |
| Current Year Minus2 | $71,762 | CurrentYearMinus2Amt |
| Current Year Minus1 | $77,916 | CurrentYearMinus1Amt |
| Current Year | $84,009 | CurrentYearAmt |
| Total | $304,141 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $456,212 | GrassrootsCeilingAmt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $442,881 | BeginningYearBalanceAmt |
| Contributions | $38,541 | ContributionsAmt |
| Investment Earnings Or Losses | $36,173 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $40,810 | OtherExpendituresAmt |
| Administrative Expenses | $2,848 | AdministrativeExpensesAmt |
| End Year Balance | $473,937 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $451,852 | BeginningYearBalanceAmt |
| Contributions | $3,628 | ContributionsAmt |
| Investment Earnings Or Losses | $781 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $10,059 | OtherExpendituresAmt |
| Administrative Expenses | $3,321 | AdministrativeExpensesAmt |
| End Year Balance | $442,881 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $471,079 | BeginningYearBalanceAmt |
| Contributions | $6,043 | ContributionsAmt |
| Investment Earnings Or Losses | $26,911 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $47,961 | OtherExpendituresAmt |
| Administrative Expenses | $4,220 | AdministrativeExpensesAmt |
| End Year Balance | $451,852 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $411,569 | BeginningYearBalanceAmt |
| Contributions | $60,083 | ContributionsAmt |
| Investment Earnings Or Losses | $45,311 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $42,119 | OtherExpendituresAmt |
| Administrative Expenses | $3,765 | AdministrativeExpensesAmt |
| End Year Balance | $471,079 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $427,130 | BeginningYearBalanceAmt |
| Contributions | $59,572 | ContributionsAmt |
| Investment Earnings Or Losses | $29,502 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $101,627 | OtherExpendituresAmt |
| Administrative Expenses | $3,008 | AdministrativeExpensesAmt |
| End Year Balance | $411,569 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.40000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.00000 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.60000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | 0 | EndowmentsHeldRelatedOrgInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $186,000 | OtherCostOrOtherBasisAmt |
| Book Value | $186,000 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $577,816 | OtherCostOrOtherBasisAmt |
| Depreciation | $192,605 | DepreciationAmt |
| Book Value | $385,211 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $195,657 | OtherCostOrOtherBasisAmt |
| Depreciation | $62,680 | DepreciationAmt |
| Book Value | $132,977 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $123,676 | OtherCostOrOtherBasisAmt |
| Depreciation | $115,710 | DepreciationAmt |
| Book Value | $7,966 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $25,120 | OtherCostOrOtherBasisAmt |
| Depreciation | $25,120 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $712,154 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | DUE TO INTERNATIONAL SOCIETY OF PHARMACOMETRICS | Desc |
| Amt | $70,650 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $70,650 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Part V, Line 4: | purpose of endowment: THE BOARD OF DIRECTORS HAS DESIGNATED CASH AND INVESTMENTS TO BE SET ASIDE TO MEET AT LEAST THREE MONTHS WORTH OF OPERATING EXPENSES. THE BOARD HAS ALSO DESIGNATED CERTAIN INVESTMENTS AND THE INCOME RELATED TO THOSE INVESTMENTS ACCOUNTS FOR PAYMENT OF THE SOCIETY'S AWARD PROGRAMS AT ITS ANNUAL MEETING. THE AWARDS PROGRAMS FOR WHICH INVESTMENTS HAVE BEEN SET ASIDE INCLUDE THE WILLIAM B. ABRAMS AWARD, THE RAWLS-PALMER AWARD, the Sheiner-Beal Award, the Gary Neil Prize, AND THE SCIENTIFIC AWARDS COMMITTEE. |
| Part X, Line 2: | The Society has evaluated its tax positions for all open tax years. Currently, the tax years open and subject to examination by the Internal Revenue Service are the 2014, 2015, and 2016 tax years. However, the Society is not currently under audit. Based on the evaluation of the Society's tax positions, management believes all tax positions taken would be upheld under an examination. Therefore, no provisions for the effects of uncertain tax positions have been recorded for the year ended December 31, 2016. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (8 entries)
| Grant TypeGrantTypeTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt |
|---|---|---|
| RAWLS-PALMER PROGRESS IN MEDICINE AWARD | 1 | $2,000 |
| FDA ABRAMS AWARD LECTURE | 1 | $500 |
| GARY NEIL PRIZE | 1 | $2,500 |
| LEON I. GOLDBERG YOUNG INVESTIGATOR AWARD | 2 | $2,000 |
| Oscar B. Hunter Award | 1 | $1,500 |
| Abrams | 1 | $1,000 |
| 2016 President Trainee Award | 30 | $17,250 |
| Henry Elliot Dist Svc award | 1 | $1,000 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Part I, Line 2: | FormAndLineReferenceDesc |
| Explanation | ASCPT MAINTAINS RECORDS TO SUBSTANTIATE THE AMOUNT OF GRANTS OR ASSISTANCE, THE GRANTEES' ELIGIBILITY FOR THE GRANTS, AND THE SELECTION CRITERIA USED TO AWARD THE GRANTS. EACH YEAR ASCPT'S AWARDS PROGRAM PROVIDES AN ARRAY OF AWARDS THAT RECOGNIZE OUTSTANDING SCIENCE AND ACHIEVEMENT IN CLINICAL PHARMACOLOGY. ASCPT'S AWARDS SPAN THE CONTINUUM OF CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE, AND THERAPEUTICS. THE ARRAY OF AWARDS IS DESIGNED TO RECOGNIZE EVERY TURNING POINT IN THE CAREER PATH FROM YOUNG INVESTIGATOR TO SEASONED SCIENTIST WITH THE FOCUS ON EXCEPTIONAL ACHIEVEMENTS IN THE DIMENSIONS THAT THE AWARDS ARE FOCUSED. CANDIDATES ARE NOMINATED BY COLLEAGUES FOR CONSIDERATION FOR AN ASCPT AWARD. ALL NOMINATIONS ARE VETTED BY AN APPOINTED AWARDS SELECTION TASK FORCE COMPRISED OF ASCPT MEMBERS. LETTERS OF RECOMMENDATION AND CURRICULUM VITAE ARE REVIEWED AND ULTIMATELY DECISIONS ARE MADE BY THE AWARDS SELECTION TASK FORCE ON EACH RECIPIENT OF AN ASCPT AWARD. GARY NEIL PRIZE FOR INNOVATION IN DRUG DEVELOPMENT ELIGIBILITY: INDIVIDUALS AS WELL AS TEAMS WHO HAVE DEMONSTRATED LEADERSHIP IN THE APPLICATION OF SIGNIFICANT, INNOVATIVE SCIENCE TO CLINICAL DRUG DEVELOPMENT. THE AWARD IS OPEN TO INDIVIDUALS FROM ALL CLINICAL PHARMACOLOGY EMPLOYMENT SECTORS. PRIZE AND PRESENTATION: THE GARY NEIL PRIZE FOR INNOVATION IN DRUG DEVELOPMENT WILL BE PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $2,500 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. LEON I. GOLDBERG EARLY INVESTIGATOR AWARD* *PREVIOUSLY LEON I. GOLDBERG YOUNG INVESTIGATOR AWARD FROM 1986-2015 ELIGIBILITY: THE NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO HAS MADE A SUBSTANTIAL CONTRIBUTION TO CLINICAL PHARMACOLOGY WITHIN 10 YEARS OF THE COMPLETION OF AN ADVANCED DEGREE AND/OR A POST-DOCTORAL FELLOWSHIP OR RESIDENCY PROGRAM. AN IMPORTANT ASPECT IS THAT THE RECIPIENT WILL BE ABLE TO DELIVER AN ENGAGING PRESENTATION ABOUT THE IMPACT OF HIS/HER RESEARCH. THE AWARD IS INTENDED TO FOSTER THE CANDIDATE'S POTENTIAL FOR SIGNIFICANT CONTRIBUTIONS TO THE FUTURE OF CLINICAL PHARMACOLOGY. THE NOMINATOR'S ASSESSMENT AND LETTERS OF RECOMMENDATION SHOULD CONTAIN EVIDENCE THAT THE CANDIDATE HAS DOCUMENTED SCIENTIFIC CONTRIBUTIONS, AS EVIDENCED BY EITHER WELL CITED PUBLICATIONS, GRANTS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS AS MAY BE RELEVANT. THERE ARE NO RESTRICTIONS CONCERNING THE SCIENTIFIC FIELD IN WHICH NOMINEES HAVE EARNED THEIR DOCTORAL DEGREES. ALTHOUGH IT IS ENCOURAGED, A NOMINEE NEED NOT BE A MEMBER OF THE SOCIETY. PRIZE AND PRESENTATION: THE LEON I. GOLDBERG EARLY INVESTIGATOR AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL DELIVER A LECTURE ON HIS/HER WORK. IN ADDITION, THE RECIPIENT OF THE AWARD WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION ARE REIMBURSED BY THE SOCIETY. OSCAR B. HUNTER CAREER AWARD IN THERAPEUTICS* *PREVIOUSLY OSCAR B. HUNTER MEMORIAL AWARD FROM 1955-2015 ELIGIBILITY: THE NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO HAS DEMONSTRATED A SUSTAINED RECORD OF LIFELONG CONTRIBUTIONS TO CLINICAL PHARMACOLOGY AND DISSEMINATION OF KNOWLEDGE WHO WILL BE ABLE TO GIVE AN ENGAGING PRESENTATION ABOUT HIS/HER CAREER AND THE IMPACT OF HIS/HER WORK. THE NOMINATOR'S ASSESSMENT AND LETTERS OF RECOMMENDATION SHOULD PROVIDE EVIDENCE OF THE NOMINEE'S EXEMPLARY CAREER AS A LEADER, INCLUDING SUFFICIENT DOCUMENTED SCIENTIFIC CONTRIBUTIONS, AS EVIDENCED BY EITHER HIGH IMPACT PUBLICATIONS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DISCOVERY, DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS AS MAY BE RELEVANT. PARTICULAR EMPHASIS SHOULD BE PROVIDED ON THE LIFETIME CONTRIBUTIONS OF THIS NOMINEE AND THE IMPACT OF HIS/HER ACCOMPLISHMENT TO CLINICAL PHARMACOLOGY. THE NOMINEE MUST BE A WELL-RECOGNIZED LEADER IN CLINICAL PHARMACOLOGY, BUT DOES NOT NEED TO BE AN ASCPT MEMBER. PRIZE AND PRESENTATION: THE OSCAR B. HUNTER CAREER AWARD IN THERAPEUTICS IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE SUMMARIZING THE WORKS THAT FORM THE BASIS OF THE AWARD. IN ADDITION, THE RECIPIENT OF THE AWARD WILL RECEIVE A BRONZE MEDAL MOUNTED ON A PLAQUE AND A $1,500 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. RAWLS-PALMER PROGRESS IN MEDICINE AWARD ELIGIBILITY: A NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO IS WIDELY RECOGNIZED FOR HIS/HER TRANSFORMATIONAL AND/OR TRANSLATIONAL DISCOVERIES OR INNOVATIVE APPROACHES IMPACTING CLINICAL PHARMACOLOGY RESEARCH AND CLINICAL PRACTICE. THE NOMINATOR'S ASSESSMENT AND LETTER(S) OF RECOMMENDATION SHOULD PROVIDE EVIDENCE OF THE NOMINEE'S EXEMPLARY RECORD, INCLUDING SUFFICIENT DOCUMENTED SCIENTIFIC CONTRIBUTIONS FROM RESEARCH THAT LEAD TO DIRECT APPLICATIONS IN PATIENT CARE, AS EVIDENCED BY EITHER WELL CITED PUBLICATIONS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS (AS MAY BE RELEVANT). A NOMINEE DOES NOT NEED TO BE AN ASCPT MEMBER. PRIZE AND PRESENTATION: THE RAWLS-PALMER PROGRESS IN MEDICINE AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE FOCUSING ON RECENT DEVELOPMENTS IN CLINICAL PHARMACOLOGY. IN ADDITION, THE RECIPIENT WILL RECEIVE A $1,000 PRIZE AND A PLAQUE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. SHEINER-BEAL PHARMACOMETRICS AWARD ELIGIBILITY: THE CANDIDATE MUST BE AN INVESTIGATOR OR LEADER WHO IS ACTIVELY ADVANCING THE SCIENTIFIC DISCIPLINE OF PHARMACOMETRICS AND/OR ITS IMPACT ON RESEARCH, DEVELOPMENT, REGULATORY EVALUATION, OR UTILIZATION OF THERAPEUTIC PRODUCTS, AND IS CAPABLE OF DELIVERING AN ENGAGING AND COMPREHENSIVE LECTURE ON PHARMACOMETRICS. THE AWARD IS INTENDED TO RECOGNIZE CLINICAL PHARMACOLOGISTS, CLINICIAN SCIENTISTS, COMPUTATIONAL SCIENTISTS, STATISTICIANS AND OTHERS IN ACADEMIA, INDUSTRY, GOVERNMENT AGENCIES, OR CONSULTING WHOSE WORK FALLS WITHIN THE SCOPE OF THE DEFINITION OF PHARMACOMETRICS. PRIZE AND PRESENTATION: THE SHEINER-BEAL PHARMACOMETRICS AWARD WILL BE PRESENTED ANNUALLY AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE SUMMARIZING THE WORKS THAT FORM THE BASIS OF THE AWARD. IN ADDITION, THE RECIPIENT WILL RECEIVE A $1,500 PRIZE AND A PLAQUE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. WILLIAM B. ABRAMS AWARD IN GERIATRIC CLINICAL PHARMACOLOGY ELIGIBILITY: A NOMINEE MUST BE AN INVESTIGATOR IN GERIATRICS WHO IS ACTIVELY INVOLVED IN HIGH-QUALITY TEACHING AND RESEARCH IN GERIATRIC CLINICAL PHARMACOLOGY. PRIZE AND PRESENTATION: THE WILLIAM B. ABRAMS AWARD IN GERIATRIC CLINICAL PHARMACOLOGY IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. HENRY W. ELLIOTT DISTINGUISHED SERVICE AWARD ELIGIBILITY: A NOMINEE MUST BE A MEMBER OF ASCPT AND CANNOT HAVE HELD THE POSITION OF PRESIDENT-ELECT OR PRESIDENT OF THE SOCIETY WITHIN THE LAST FIVE YEARS. THE ESSENTIAL CRITERION IS DOCUMENTED EVIDENCE OF EXCELLENT SERVICE TO THE ORGANIZATION. ONE OR TWO OUTSTANDING ACTS OF SERVICE OR A LONG RECORD OF MANY ACTS OF SERVICE MAY JUSTIFY THE AWARD. THE RECIPIENT SHOULD HAVE A RECORD OF CONTINUOUS SERVICE TO THE SOCIETY, INCLUDING ONE OR MANY MAJOR ACCOMPLISHMENTS. PRIZE AND PRESENTATION: THE HENRY W. ELLIOTT DISTINGUISHED SERVICE AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (2 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sharon J Swan FASAE CAE | ||||||||||||||
| Chief Executive Officer | $363,316 | $0 | $0 | $0 | $21,095 | $0 | $35,000 | $0 | $11,265 | $0 | $430,676 | $0 | $0 | $0 |
| Elise Laffman-Johnson | ||||||||||||||
| Chief Operating Officer | $163,642 | $0 | $10,000 | $0 | $396 | $0 | $12,303 | $0 | $1,100 | $0 | $187,441 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Part I, Line 7 | FormAndLineReferenceDesc |
| Explanation | The process for calculating the staff bonus is dependent on performance and discussions with the Compensation Committee and the CEO. The CEO's bonus is calculated based on achievement of incentive objectives that are approved by the Compensation Committee. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part VI, Section A, line 6 | The Society has two classes of members: FUll Member and Trainee/Student Member Full Member: For applicants who have earned a doctorate degree or equivalent in any of the biomedical sciences. Also for applicants in executive and leadership roles in related organizations. Applicants must demonstrate a sincere interest in, and contributions to, human pharmacology and therapeutics through publications, grants, patents, governmental reports, company reports, etc. Trainee/STudent Member: For applicants currently enrolled in a post-doctoral training program who have demonstrated an interest in human pharmacology and therapeutics. Also for applicants who are pursuing a post-baccalaureate degree and who possess an interest in human pharmacology and therapeutics. |
| Form 990, Part VI, Section A, line 7a | Members shall have such voting privileges as are determined from time to time by the Society's Governing Board and shall vote in such manner as determined by the Governing Board. |
| Form 990, Part VI, Section A, line 7b | Any changes to the organization's bylaws are subject to approval by the full members. |
| Form 990, Part VI, Section B, line 11b | The Form 990 is reviewed by the ASCPT Executive Director and ASCPT legal counsel following preparation by the Society's accountants. The officers of ASCPT review the document prior to it being filed. The Board is informed about the preparation and filing of the Form 990 and the return is made available at any time to any Board Member for his or her review. |
| Form 990, Part VI, Section B, line 12c | ALL ASCPT VOLUNTEER LEADERS COMPLETE A WRITTEN CONFLICT OF INTEREST DISCLOSURE. THE CEO, LEGAL COUNSEL, AND SENIOR STAFF ARE AWARE OF CONFLICTS, AND DISCUSS ANY ACTUAL OR POTENTIAL COI ISSUES. CONFLICT OF INTEREST IS DISCUSSED AT THE BEGINNING OF EVERY BOARD OF DIRECTORS CONFERENCE CALL, WITH BOARD MEMBERS BEING ASKED TO DECLARE ANY CONFLICTS AT THE BEGINNING OF THE CALL. |
| Form 990, Part VI, Section B, line 15 | THE EXECUTIVE DIRECTOR'S COMPENSATION IS DETERMINED BY THE ASCPT COMPENSATION COMMITTEE USING COMPARABILITY DATA. COMPENSATION OF KEY EMPLOYEES IS DETERMINED BY THE EXECUTIVE DIRECTOR USING COMPARABILITY DATA. |
| Form 990, Part VI, Section C, line 19 | The governing documents and conflict of interest policy are available on the ASCPT website. Financial statements are available upon request. |
| Form 990, Part XII, Line 1: | THE SOCIETY PREPARES ITS FINANCIAL STATEMENTS ON THE MODIFIED CASH BASIS OF ACCOUnTING. REVENUES ARE RECOGNIZED WHEN COLLECTED RATHER THAN WHEN EARNED, AND EXPENSES ARE GENERALLY RECOGNIZED WHEN PAID RATHER THAN WHEN INCURRED. THE MODIFIED CASH BASIS OF ACCOUNTING INCLUDES THE RECORDING OF DEPRECIATION ON PROPERTY AND EQuipMENT, AND REALIZED AND UNREALIZED GAINS AND LOSSES ON INVESTMENTS. |
Comments